Advertisement

Index by author

July 01, 2005; Volume 33,Issue 7

A

  1. Adelsberger, Jennifer

    1. INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913

  2. Annaert, Pieter

    1. EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES
      Dirk Roymans, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens and Willem Meuldermans
      Drug Metabolism and Disposition July 2005, 33 (7) 1004-1016; DOI: https://doi.org/10.1124/dmd.104.003046

B

  1. Baillie, Thomas A.

    1. INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913

  2. Barama, Azemi

    1. CYP3A5 GENETIC POLYMORPHISMS IN DIFFERENT ETHNIC POPULATIONS
      Jean-Nicholas Roy, Julie Lajoie, Lynn S. Zijenah, Azemi Barama, Charles Poirier, Brian J. Ward and Michel Roger
      Drug Metabolism and Disposition July 2005, 33 (7) 884-887; DOI: https://doi.org/10.1124/dmd.105.003822

  3. Baumann, Frank

    1. SYNTHESIS AND CHARACTERIZATION OF SOME NEW PHASE II METABOLITES OF THE ALKYLATOR BENDAMUSTINE AND THEIR IDENTIFICATION IN HUMAN BILE, URINE, AND PLASMA FROM PATIENTS WITH CHOLANGIOCARCINOMA
      Jens Teichert, Reinhard Sohr, Frank Baumann, Lothar Hennig, Karlheinz Merkle, Karel Caca and Rainer Preiss
      Drug Metabolism and Disposition July 2005, 33 (7) 984-992; DOI: https://doi.org/10.1124/dmd.105.003624

  4. Beijnen, Jos H.

    1. MIDAZOLAM AND CYCLOSPORIN A METABOLISM IN TRANSGENIC MICE WITH LIVER-SPECIFIC EXPRESSION OF HUMAN CYP3A4
      Antonius E. van Herwaarden, Johan W. Smit, Rolf W. Sparidans, Els Wagenaar, Cornelia M. M. van der Kruijssen, Jan H. M. Schellens, Jos H. Beijnen and Alfred H. Schinkel
      Drug Metabolism and Disposition July 2005, 33 (7) 892-895; DOI: https://doi.org/10.1124/dmd.105.004721

  5. Benlhabib, E.

    1. MONOCLONAL NICOTINE-SPECIFIC ANTIBODIES REDUCE NICOTINE DISTRIBUTION TO BRAIN IN RATS: DOSE- AND AFFINITY-RESPONSE RELATIONSHIPS
      D. E. Keyler, S. A. Roiko, E. Benlhabib, M. G. LeSage, J. V. St. Peter, S. Stewart, S. Fuller, C. T. Le and P. R. Pentel
      Drug Metabolism and Disposition July 2005, 33 (7) 1056-1061; DOI: https://doi.org/10.1124/dmd.105.004234

  6. Bigler, Jeannette

    1. GLUCURONIDATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: IDENTIFYING THE ENZYMES RESPONSIBLE IN HUMAN LIVER MICROSOMES
      Gwendolyn E. Kuehl, Johanna W. Lampe, John D. Potter and Jeannette Bigler
      Drug Metabolism and Disposition July 2005, 33 (7) 1027-1035; DOI: https://doi.org/10.1124/dmd.104.002527

  7. Blough, David

    1. CONTRIBUTION OF CYP3A5 TO HEPATIC AND RENAL IFOSFAMIDE N-DECHLOROETHYLATION
      Jeannine S. McCune, Linda J. Risler, Brian R. Phillips, Kenneth E. Thummel, David Blough and Danny D. Shen
      Drug Metabolism and Disposition July 2005, 33 (7) 1074-1081; DOI: https://doi.org/10.1124/dmd.104.002279

  8. Boothe-Genthe, Catherine

    1. INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913

  9. Borges, Silvana

    1. DEXTROMETHORPHAN TO DEXTRORPHAN URINARY METABOLIC RATIO DOES NOT REFLECT DEXTROMETHORPHAN ORAL CLEARANCE
      Silvana Borges, Lang Li, Mitchell A. Hamman, David R. Jones, Stephen D. Hall and J. Christopher Gorski
      Drug Metabolism and Disposition July 2005, 33 (7) 1052-1055; DOI: https://doi.org/10.1124/dmd.104.003459

  10. Bratton, Stacie

    1. LITHOCHOLIC ACID DECREASES EXPRESSION OF UGT2B7 IN CACO-2 CELLS: A POTENTIAL ROLE FOR A NEGATIVE FARNESOID X RECEPTOR RESPONSE ELEMENT
      Yuan Lu, Jean-Marie Heydel, Xin Li, Stacie Bratton, Tim Lindblom and Anna Radominska-Pandya
      Drug Metabolism and Disposition July 2005, 33 (7) 937-946; DOI: https://doi.org/10.1124/dmd.104.003061

  11. Brown, Cheri M.

    1. INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913

  12. Brunner, Janice

    1. INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913

C

  1. Caca, Karel

    1. SYNTHESIS AND CHARACTERIZATION OF SOME NEW PHASE II METABOLITES OF THE ALKYLATOR BENDAMUSTINE AND THEIR IDENTIFICATION IN HUMAN BILE, URINE, AND PLASMA FROM PATIENTS WITH CHOLANGIOCARCINOMA
      Jens Teichert, Reinhard Sohr, Frank Baumann, Lothar Hennig, Karlheinz Merkle, Karel Caca and Rainer Preiss
      Drug Metabolism and Disposition July 2005, 33 (7) 984-992; DOI: https://doi.org/10.1124/dmd.105.003624

  2. Caldwell, Stuart T.

    1. DISPOSITION AND METABOLISM OF [2-14C]QUERCETIN-4′-GLUCOSIDE IN RATS
      Brigitte A. Graf, William Mullen, Stuart T. Caldwell, Richard C. Hartley, Garry G. Duthie, Michael E. J. Lean, Alan Crozier and Christine A. Edwards
      Drug Metabolism and Disposition July 2005, 33 (7) 1036-1043; DOI: https://doi.org/10.1124/dmd.104.002691

  3. Carlini, Edward

    1. INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913

  4. Cascorbi, Ingolf

    1. VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION
      Henriette E. Meyer zu Schwabedissen, Gabriele Jedlitschky, Matthias Gratz, Sierk Haenisch, Knud Linnemann, Christoph Fusch, Ingolf Cascorbi and Heyo K. Kroemer
      Drug Metabolism and Disposition July 2005, 33 (7) 896-904; DOI: https://doi.org/10.1124/dmd.104.003335

  5. Catania, Viviana A.

    1. PREVENTION OF MRP2 ACTIVITY IMPAIRMENT IN ETHINYLESTRADIOL-INDUCED CHOLESTASIS BY URSODEOXYCHOLATE IN THE RAT
      Fernando A. Crocenzi, Vanesa D'Andrea, Viviana A. Catania, Marcelo G. Luquita, José M. Pellegrino, J. Elena Ochoa, Aldo D. Mottino and Enrique J. Sánchez Pozzi
      Drug Metabolism and Disposition July 2005, 33 (7) 888-891; DOI: https://doi.org/10.1124/dmd.104.003533

  6. Chen, Chuan

    1. TISSUE DISTRIBUTION AND ONTOGENY OF MOUSE ORGANIC ANION TRANSPORTING POLYPEPTIDES (OATPS)
      Xingguo Cheng, Jonathan Maher, Chuan Chen and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 1062-1073; DOI: https://doi.org/10.1124/dmd.105.003640

  7. Cheng, Xingguo

    1. TISSUE DISTRIBUTION AND ONTOGENY OF MOUSE ORGANIC ANION TRANSPORTING POLYPEPTIDES (OATPS)
      Xingguo Cheng, Jonathan Maher, Chuan Chen and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 1062-1073; DOI: https://doi.org/10.1124/dmd.105.003640
    2. TISSUE DISTRIBUTION AND HEPATIC AND RENAL ONTOGENY OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) FAMILY IN MICE
      Jonathan M. Maher, Angela L. Slitt, Nathan J. Cherrington, Xingguo Cheng and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 947-955; DOI: https://doi.org/10.1124/dmd.105.003780
    3. INDUCTION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN FAMILY OF TRANSPORTERS BY CHEMICAL ACTIVATORS OF RECEPTOR-MEDIATED PATHWAYS IN MOUSE LIVER
      Jonathan M. Maher, Xingguo Cheng, Angela L. Slitt, Matthew Z. Dieter and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 956-962; DOI: https://doi.org/10.1124/dmd.105.003798

  8. Cherrington, Nathan J.

    1. TISSUE DISTRIBUTION AND HEPATIC AND RENAL ONTOGENY OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) FAMILY IN MICE
      Jonathan M. Maher, Angela L. Slitt, Nathan J. Cherrington, Xingguo Cheng and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 947-955; DOI: https://doi.org/10.1124/dmd.105.003780

  9. Chiba, Kan

    1. IDENTIFICATION OF HMG-CoA REDUCTASE INHIBITORS AS ACTIVATORS FOR HUMAN, MOUSE AND RAT CONSTITUTIVE ANDROSTANE RECEPTOR
      Kaoru Kobayashi, Yosuke Yamanaka, Norihiko Iwazaki, Ikumi Nakajo, Masakiyo Hosokawa, Masahiko Negishi and Kan Chiba
      Drug Metabolism and Disposition July 2005, 33 (7) 924-929; DOI: https://doi.org/10.1124/dmd.104.002741

  10. Ciecko, Patrice

    1. INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913

  11. Crocenzi, Fernando A.

    1. PREVENTION OF MRP2 ACTIVITY IMPAIRMENT IN ETHINYLESTRADIOL-INDUCED CHOLESTASIS BY URSODEOXYCHOLATE IN THE RAT
      Fernando A. Crocenzi, Vanesa D'Andrea, Viviana A. Catania, Marcelo G. Luquita, José M. Pellegrino, J. Elena Ochoa, Aldo D. Mottino and Enrique J. Sánchez Pozzi
      Drug Metabolism and Disposition July 2005, 33 (7) 888-891; DOI: https://doi.org/10.1124/dmd.104.003533

  12. Crozier, Alan

    1. DISPOSITION AND METABOLISM OF [2-14C]QUERCETIN-4′-GLUCOSIDE IN RATS
      Brigitte A. Graf, William Mullen, Stuart T. Caldwell, Richard C. Hartley, Garry G. Duthie, Michael E. J. Lean, Alan Crozier and Christine A. Edwards
      Drug Metabolism and Disposition July 2005, 33 (7) 1036-1043; DOI: https://doi.org/10.1124/dmd.104.002691

D

  1. D'Andrea, Vanesa

    1. PREVENTION OF MRP2 ACTIVITY IMPAIRMENT IN ETHINYLESTRADIOL-INDUCED CHOLESTASIS BY URSODEOXYCHOLATE IN THE RAT
      Fernando A. Crocenzi, Vanesa D'Andrea, Viviana A. Catania, Marcelo G. Luquita, José M. Pellegrino, J. Elena Ochoa, Aldo D. Mottino and Enrique J. Sánchez Pozzi
      Drug Metabolism and Disposition July 2005, 33 (7) 888-891; DOI: https://doi.org/10.1124/dmd.104.003533

  2. Dieter, Matthew Z.

    1. INDUCTION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN FAMILY OF TRANSPORTERS BY CHEMICAL ACTIVATORS OF RECEPTOR-MEDIATED PATHWAYS IN MOUSE LIVER
      Jonathan M. Maher, Xingguo Cheng, Angela L. Slitt, Matthew Z. Dieter and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 956-962; DOI: https://doi.org/10.1124/dmd.105.003798

  3. Dong, Junxing

    1. METABOLIC PROFILE OF 1,5-DICAFFEOYLQUINIC ACID IN RATS, AN IN VIVO AND IN VITRO STUDY
      Bo Yang, Zhiyun Meng, Junxing Dong, Liangping Yan, Libo Zou, Zhongming Tang and Guifang Dou
      Drug Metabolism and Disposition July 2005, 33 (7) 930-936; DOI: https://doi.org/10.1124/dmd.104.002154

  4. Dou, Guifang

    1. METABOLIC PROFILE OF 1,5-DICAFFEOYLQUINIC ACID IN RATS, AN IN VIVO AND IN VITRO STUDY
      Bo Yang, Zhiyun Meng, Junxing Dong, Liangping Yan, Libo Zou, Zhongming Tang and Guifang Dou
      Drug Metabolism and Disposition July 2005, 33 (7) 930-936; DOI: https://doi.org/10.1124/dmd.104.002154

  5. Duthie, Garry G.

    1. DISPOSITION AND METABOLISM OF [2-14C]QUERCETIN-4′-GLUCOSIDE IN RATS
      Brigitte A. Graf, William Mullen, Stuart T. Caldwell, Richard C. Hartley, Garry G. Duthie, Michael E. J. Lean, Alan Crozier and Christine A. Edwards
      Drug Metabolism and Disposition July 2005, 33 (7) 1036-1043; DOI: https://doi.org/10.1124/dmd.104.002691

E

  1. Edwards, Christine A.

    1. DISPOSITION AND METABOLISM OF [2-14C]QUERCETIN-4′-GLUCOSIDE IN RATS
      Brigitte A. Graf, William Mullen, Stuart T. Caldwell, Richard C. Hartley, Garry G. Duthie, Michael E. J. Lean, Alan Crozier and Christine A. Edwards
      Drug Metabolism and Disposition July 2005, 33 (7) 1036-1043; DOI: https://doi.org/10.1124/dmd.104.002691

  2. Evans, Ronald M.

    1. ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES
      Trisha L. Noreault, Vsevolod E. Kostrubsky, Sheryl G. Wood, Ralph C. Nichols, Stephen C. Strom, Heidi W. Trask, Steven A. Wrighton, Ronald M. Evans, Judith M. Jacobs, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2005, 33 (7) 993-1003; DOI: https://doi.org/10.1124/dmd.105.003954

F

  1. Finel, Moshe

    1. KINETIC CHARACTERIZATION OF THE 1A SUBFAMILY OF RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Leena Luukkanen, Jyrki Taskinen, Mika Kurkela, Risto Kostiainen, Jouni Hirvonen and Moshe Finel
      Drug Metabolism and Disposition July 2005, 33 (7) 1017-1026; DOI: https://doi.org/10.1124/dmd.105.004093

  2. Fuller, S.

    1. MONOCLONAL NICOTINE-SPECIFIC ANTIBODIES REDUCE NICOTINE DISTRIBUTION TO BRAIN IN RATS: DOSE- AND AFFINITY-RESPONSE RELATIONSHIPS
      D. E. Keyler, S. A. Roiko, E. Benlhabib, M. G. LeSage, J. V. St. Peter, S. Stewart, S. Fuller, C. T. Le and P. R. Pentel
      Drug Metabolism and Disposition July 2005, 33 (7) 1056-1061; DOI: https://doi.org/10.1124/dmd.105.004234

  3. Fusch, Christoph

    1. VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION
      Henriette E. Meyer zu Schwabedissen, Gabriele Jedlitschky, Matthias Gratz, Sierk Haenisch, Knud Linnemann, Christoph Fusch, Ingolf Cascorbi and Heyo K. Kroemer
      Drug Metabolism and Disposition July 2005, 33 (7) 896-904; DOI: https://doi.org/10.1124/dmd.104.003335

  4. Fuse, Eiichi

    1. P-GLYCOPROTEIN PLAYS A MAJOR ROLE IN THE EFFLUX OF FEXOFENADINE IN THE SMALL INTESTINE AND BLOOD-BRAIN BARRIER, BUT ONLY A LIMITED ROLE IN ITS BILIARY EXCRETION
      Harunobu Tahara, Hiroyuki Kusuhara, Eiichi Fuse and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2005, 33 (7) 963-968; DOI: https://doi.org/10.1124/dmd.105.004192

G

  1. Gibson, Christopher R.

    1. INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913

  2. Gorski, J. Christopher

    1. DEXTROMETHORPHAN TO DEXTRORPHAN URINARY METABOLIC RATIO DOES NOT REFLECT DEXTROMETHORPHAN ORAL CLEARANCE
      Silvana Borges, Lang Li, Mitchell A. Hamman, David R. Jones, Stephen D. Hall and J. Christopher Gorski
      Drug Metabolism and Disposition July 2005, 33 (7) 1052-1055; DOI: https://doi.org/10.1124/dmd.104.003459

  3. Gotoh, Yukiko

    1. REGULATION OF THE CELL SURFACE EXPRESSION OF HUMAN BCRP/ABCG2 BY THE PHOSPHORYLATION STATE OF AKT IN POLARIZED CELLS
      Tappei Takada, Hiroshi Suzuki, Yukiko Gotoh and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2005, 33 (7) 905-909; DOI: https://doi.org/10.1124/dmd.104.003228

  4. Graf, Brigitte A.

    1. DISPOSITION AND METABOLISM OF [2-14C]QUERCETIN-4′-GLUCOSIDE IN RATS
      Brigitte A. Graf, William Mullen, Stuart T. Caldwell, Richard C. Hartley, Garry G. Duthie, Michael E. J. Lean, Alan Crozier and Christine A. Edwards
      Drug Metabolism and Disposition July 2005, 33 (7) 1036-1043; DOI: https://doi.org/10.1124/dmd.104.002691

  5. Gräter, Frauke

    1. POSSIBLE PATHWAY(S) OF TESTOSTERONE EGRESS FROM THE ACTIVE SITE OF CYTOCHROME P450 2B1: A STEERED MOLECULAR DYNAMICS SIMULATION
      Weihua Li, Hong Liu, Emily E. Scott, Frauke Gräter, James R. Halpert, Xiaoming Luo, Jianhua Shen and Hualiang Jiang
      Drug Metabolism and Disposition July 2005, 33 (7) 910-919; DOI: https://doi.org/10.1124/dmd.105.004200

  6. Gratz, Matthias

    1. VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION
      Henriette E. Meyer zu Schwabedissen, Gabriele Jedlitschky, Matthias Gratz, Sierk Haenisch, Knud Linnemann, Christoph Fusch, Ingolf Cascorbi and Heyo K. Kroemer
      Drug Metabolism and Disposition July 2005, 33 (7) 896-904; DOI: https://doi.org/10.1124/dmd.104.003335

H

  1. Haenisch, Sierk

    1. VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION
      Henriette E. Meyer zu Schwabedissen, Gabriele Jedlitschky, Matthias Gratz, Sierk Haenisch, Knud Linnemann, Christoph Fusch, Ingolf Cascorbi and Heyo K. Kroemer
      Drug Metabolism and Disposition July 2005, 33 (7) 896-904; DOI: https://doi.org/10.1124/dmd.104.003335

  2. Hall, Stephen D.

    1. DEXTROMETHORPHAN TO DEXTRORPHAN URINARY METABOLIC RATIO DOES NOT REFLECT DEXTROMETHORPHAN ORAL CLEARANCE
      Silvana Borges, Lang Li, Mitchell A. Hamman, David R. Jones, Stephen D. Hall and J. Christopher Gorski
      Drug Metabolism and Disposition July 2005, 33 (7) 1052-1055; DOI: https://doi.org/10.1124/dmd.104.003459

  3. Halpert, James R.

    1. POSSIBLE PATHWAY(S) OF TESTOSTERONE EGRESS FROM THE ACTIVE SITE OF CYTOCHROME P450 2B1: A STEERED MOLECULAR DYNAMICS SIMULATION
      Weihua Li, Hong Liu, Emily E. Scott, Frauke Gräter, James R. Halpert, Xiaoming Luo, Jianhua Shen and Hualiang Jiang
      Drug Metabolism and Disposition July 2005, 33 (7) 910-919; DOI: https://doi.org/10.1124/dmd.105.004200

  4. Hamman, Mitchell A.

    1. DEXTROMETHORPHAN TO DEXTRORPHAN URINARY METABOLIC RATIO DOES NOT REFLECT DEXTROMETHORPHAN ORAL CLEARANCE
      Silvana Borges, Lang Li, Mitchell A. Hamman, David R. Jones, Stephen D. Hall and J. Christopher Gorski
      Drug Metabolism and Disposition July 2005, 33 (7) 1052-1055; DOI: https://doi.org/10.1124/dmd.104.003459

  5. Hartley, Richard C.

    1. DISPOSITION AND METABOLISM OF [2-14C]QUERCETIN-4′-GLUCOSIDE IN RATS
      Brigitte A. Graf, William Mullen, Stuart T. Caldwell, Richard C. Hartley, Garry G. Duthie, Michael E. J. Lean, Alan Crozier and Christine A. Edwards
      Drug Metabolism and Disposition July 2005, 33 (7) 1036-1043; DOI: https://doi.org/10.1124/dmd.104.002691

  6. Hendrickx, Jan

    1. EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES
      Dirk Roymans, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens and Willem Meuldermans
      Drug Metabolism and Disposition July 2005, 33 (7) 1004-1016; DOI: https://doi.org/10.1124/dmd.104.003046

  7. Hennig, Lothar

    1. SYNTHESIS AND CHARACTERIZATION OF SOME NEW PHASE II METABOLITES OF THE ALKYLATOR BENDAMUSTINE AND THEIR IDENTIFICATION IN HUMAN BILE, URINE, AND PLASMA FROM PATIENTS WITH CHOLANGIOCARCINOMA
      Jens Teichert, Reinhard Sohr, Frank Baumann, Lothar Hennig, Karlheinz Merkle, Karel Caca and Rainer Preiss
      Drug Metabolism and Disposition July 2005, 33 (7) 984-992; DOI: https://doi.org/10.1124/dmd.105.003624

  8. Heydel, Jean-Marie

    1. LITHOCHOLIC ACID DECREASES EXPRESSION OF UGT2B7 IN CACO-2 CELLS: A POTENTIAL ROLE FOR A NEGATIVE FARNESOID X RECEPTOR RESPONSE ELEMENT
      Yuan Lu, Jean-Marie Heydel, Xin Li, Stacie Bratton, Tim Lindblom and Anna Radominska-Pandya
      Drug Metabolism and Disposition July 2005, 33 (7) 937-946; DOI: https://doi.org/10.1124/dmd.104.003061

  9. Hirvonen, Jouni

    1. KINETIC CHARACTERIZATION OF THE 1A SUBFAMILY OF RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Leena Luukkanen, Jyrki Taskinen, Mika Kurkela, Risto Kostiainen, Jouni Hirvonen and Moshe Finel
      Drug Metabolism and Disposition July 2005, 33 (7) 1017-1026; DOI: https://doi.org/10.1124/dmd.105.004093

  10. Hosokawa, Masakiyo

    1. IDENTIFICATION OF HMG-CoA REDUCTASE INHIBITORS AS ACTIVATORS FOR HUMAN, MOUSE AND RAT CONSTITUTIVE ANDROSTANE RECEPTOR
      Kaoru Kobayashi, Yosuke Yamanaka, Norihiko Iwazaki, Ikumi Nakajo, Masakiyo Hosokawa, Masahiko Negishi and Kan Chiba
      Drug Metabolism and Disposition July 2005, 33 (7) 924-929; DOI: https://doi.org/10.1124/dmd.104.002741

I

  1. Iwazaki, Norihiko

    1. IDENTIFICATION OF HMG-CoA REDUCTASE INHIBITORS AS ACTIVATORS FOR HUMAN, MOUSE AND RAT CONSTITUTIVE ANDROSTANE RECEPTOR
      Kaoru Kobayashi, Yosuke Yamanaka, Norihiko Iwazaki, Ikumi Nakajo, Masakiyo Hosokawa, Masahiko Negishi and Kan Chiba
      Drug Metabolism and Disposition July 2005, 33 (7) 924-929; DOI: https://doi.org/10.1124/dmd.104.002741

J

  1. Jacobs, Judith M.

    1. ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES
      Trisha L. Noreault, Vsevolod E. Kostrubsky, Sheryl G. Wood, Ralph C. Nichols, Stephen C. Strom, Heidi W. Trask, Steven A. Wrighton, Ronald M. Evans, Judith M. Jacobs, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2005, 33 (7) 993-1003; DOI: https://doi.org/10.1124/dmd.105.003954

  2. Jedlitschky, Gabriele

    1. VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION
      Henriette E. Meyer zu Schwabedissen, Gabriele Jedlitschky, Matthias Gratz, Sierk Haenisch, Knud Linnemann, Christoph Fusch, Ingolf Cascorbi and Heyo K. Kroemer
      Drug Metabolism and Disposition July 2005, 33 (7) 896-904; DOI: https://doi.org/10.1124/dmd.104.003335

  3. Jiang, Hualiang

    1. POSSIBLE PATHWAY(S) OF TESTOSTERONE EGRESS FROM THE ACTIVE SITE OF CYTOCHROME P450 2B1: A STEERED MOLECULAR DYNAMICS SIMULATION
      Weihua Li, Hong Liu, Emily E. Scott, Frauke Gräter, James R. Halpert, Xiaoming Luo, Jianhua Shen and Hualiang Jiang
      Drug Metabolism and Disposition July 2005, 33 (7) 910-919; DOI: https://doi.org/10.1124/dmd.105.004200

  4. Jones, David R.

    1. DEXTROMETHORPHAN TO DEXTRORPHAN URINARY METABOLIC RATIO DOES NOT REFLECT DEXTROMETHORPHAN ORAL CLEARANCE
      Silvana Borges, Lang Li, Mitchell A. Hamman, David R. Jones, Stephen D. Hall and J. Christopher Gorski
      Drug Metabolism and Disposition July 2005, 33 (7) 1052-1055; DOI: https://doi.org/10.1124/dmd.104.003459

K

  1. Kamel, Amin

    1. CHARACTERIZATION OF A NOVEL METABOLITE INTERMEDIATE OF ZIPRASIDONE IN HEPATIC CYTOSOLIC FRACTIONS OF RAT, DOG, AND HUMAN BY ESI-MS/MS, HYDROGEN/DEUTERIUM EXCHANGE, AND CHEMICAL DERIVATIZATION
      Zhuang Miao, Amin Kamel and Chandra Prakash
      Drug Metabolism and Disposition July 2005, 33 (7) 879-883; DOI: https://doi.org/10.1124/dmd.105.004036

  2. Keyler, D. E.

    1. MONOCLONAL NICOTINE-SPECIFIC ANTIBODIES REDUCE NICOTINE DISTRIBUTION TO BRAIN IN RATS: DOSE- AND AFFINITY-RESPONSE RELATIONSHIPS
      D. E. Keyler, S. A. Roiko, E. Benlhabib, M. G. LeSage, J. V. St. Peter, S. Stewart, S. Fuller, C. T. Le and P. R. Pentel
      Drug Metabolism and Disposition July 2005, 33 (7) 1056-1061; DOI: https://doi.org/10.1124/dmd.105.004234

  3. Klaassen, Curtis D.

    1. TISSUE DISTRIBUTION AND ONTOGENY OF MOUSE ORGANIC ANION TRANSPORTING POLYPEPTIDES (OATPS)
      Xingguo Cheng, Jonathan Maher, Chuan Chen and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 1062-1073; DOI: https://doi.org/10.1124/dmd.105.003640
    2. TISSUE DISTRIBUTION AND HEPATIC AND RENAL ONTOGENY OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) FAMILY IN MICE
      Jonathan M. Maher, Angela L. Slitt, Nathan J. Cherrington, Xingguo Cheng and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 947-955; DOI: https://doi.org/10.1124/dmd.105.003780
    3. INDUCTION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN FAMILY OF TRANSPORTERS BY CHEMICAL ACTIVATORS OF RECEPTOR-MEDIATED PATHWAYS IN MOUSE LIVER
      Jonathan M. Maher, Xingguo Cheng, Angela L. Slitt, Matthew Z. Dieter and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 956-962; DOI: https://doi.org/10.1124/dmd.105.003798

  4. Kobayashi, Kaoru

    1. IDENTIFICATION OF HMG-CoA REDUCTASE INHIBITORS AS ACTIVATORS FOR HUMAN, MOUSE AND RAT CONSTITUTIVE ANDROSTANE RECEPTOR
      Kaoru Kobayashi, Yosuke Yamanaka, Norihiko Iwazaki, Ikumi Nakajo, Masakiyo Hosokawa, Masahiko Negishi and Kan Chiba
      Drug Metabolism and Disposition July 2005, 33 (7) 924-929; DOI: https://doi.org/10.1124/dmd.104.002741

  5. Kostiainen, Risto

    1. KINETIC CHARACTERIZATION OF THE 1A SUBFAMILY OF RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Leena Luukkanen, Jyrki Taskinen, Mika Kurkela, Risto Kostiainen, Jouni Hirvonen and Moshe Finel
      Drug Metabolism and Disposition July 2005, 33 (7) 1017-1026; DOI: https://doi.org/10.1124/dmd.105.004093

  6. Kostrubsky, Vsevolod E.

    1. ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES
      Trisha L. Noreault, Vsevolod E. Kostrubsky, Sheryl G. Wood, Ralph C. Nichols, Stephen C. Strom, Heidi W. Trask, Steven A. Wrighton, Ronald M. Evans, Judith M. Jacobs, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2005, 33 (7) 993-1003; DOI: https://doi.org/10.1124/dmd.105.003954

  7. Kroemer, Heyo K.

    1. VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION
      Henriette E. Meyer zu Schwabedissen, Gabriele Jedlitschky, Matthias Gratz, Sierk Haenisch, Knud Linnemann, Christoph Fusch, Ingolf Cascorbi and Heyo K. Kroemer
      Drug Metabolism and Disposition July 2005, 33 (7) 896-904; DOI: https://doi.org/10.1124/dmd.104.003335

  8. Krolikowski, Paul

    1. INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913

  9. Kuehl, Gwendolyn E.

    1. GLUCURONIDATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: IDENTIFYING THE ENZYMES RESPONSIBLE IN HUMAN LIVER MICROSOMES
      Gwendolyn E. Kuehl, Johanna W. Lampe, John D. Potter and Jeannette Bigler
      Drug Metabolism and Disposition July 2005, 33 (7) 1027-1035; DOI: https://doi.org/10.1124/dmd.104.002527

  10. Kurkela, Mika

    1. KINETIC CHARACTERIZATION OF THE 1A SUBFAMILY OF RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Leena Luukkanen, Jyrki Taskinen, Mika Kurkela, Risto Kostiainen, Jouni Hirvonen and Moshe Finel
      Drug Metabolism and Disposition July 2005, 33 (7) 1017-1026; DOI: https://doi.org/10.1124/dmd.105.004093

  11. Kusuhara, Hiroyuki

    1. P-GLYCOPROTEIN PLAYS A MAJOR ROLE IN THE EFFLUX OF FEXOFENADINE IN THE SMALL INTESTINE AND BLOOD-BRAIN BARRIER, BUT ONLY A LIMITED ROLE IN ITS BILIARY EXCRETION
      Harunobu Tahara, Hiroyuki Kusuhara, Eiichi Fuse and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2005, 33 (7) 963-968; DOI: https://doi.org/10.1124/dmd.105.004192

L

  1. Lajoie, Julie

    1. CYP3A5 GENETIC POLYMORPHISMS IN DIFFERENT ETHNIC POPULATIONS
      Jean-Nicholas Roy, Julie Lajoie, Lynn S. Zijenah, Azemi Barama, Charles Poirier, Brian J. Ward and Michel Roger
      Drug Metabolism and Disposition July 2005, 33 (7) 884-887; DOI: https://doi.org/10.1124/dmd.105.003822

  2. Lampe, Johanna W.

    1. GLUCURONIDATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: IDENTIFYING THE ENZYMES RESPONSIBLE IN HUMAN LIVER MICROSOMES
      Gwendolyn E. Kuehl, Johanna W. Lampe, John D. Potter and Jeannette Bigler
      Drug Metabolism and Disposition July 2005, 33 (7) 1027-1035; DOI: https://doi.org/10.1124/dmd.104.002527

  3. Le, C. T.

    1. MONOCLONAL NICOTINE-SPECIFIC ANTIBODIES REDUCE NICOTINE DISTRIBUTION TO BRAIN IN RATS: DOSE- AND AFFINITY-RESPONSE RELATIONSHIPS
      D. E. Keyler, S. A. Roiko, E. Benlhabib, M. G. LeSage, J. V. St. Peter, S. Stewart, S. Fuller, C. T. Le and P. R. Pentel
      Drug Metabolism and Disposition July 2005, 33 (7) 1056-1061; DOI: https://doi.org/10.1124/dmd.105.004234

  4. Lean, Michael E. J.

    1. DISPOSITION AND METABOLISM OF [2-14C]QUERCETIN-4′-GLUCOSIDE IN RATS
      Brigitte A. Graf, William Mullen, Stuart T. Caldwell, Richard C. Hartley, Garry G. Duthie, Michael E. J. Lean, Alan Crozier and Christine A. Edwards
      Drug Metabolism and Disposition July 2005, 33 (7) 1036-1043; DOI: https://doi.org/10.1124/dmd.104.002691

  5. LeSage, M. G.

    1. MONOCLONAL NICOTINE-SPECIFIC ANTIBODIES REDUCE NICOTINE DISTRIBUTION TO BRAIN IN RATS: DOSE- AND AFFINITY-RESPONSE RELATIONSHIPS
      D. E. Keyler, S. A. Roiko, E. Benlhabib, M. G. LeSage, J. V. St. Peter, S. Stewart, S. Fuller, C. T. Le and P. R. Pentel
      Drug Metabolism and Disposition July 2005, 33 (7) 1056-1061; DOI: https://doi.org/10.1124/dmd.105.004234

  6. Li, Lang

    1. DEXTROMETHORPHAN TO DEXTRORPHAN URINARY METABOLIC RATIO DOES NOT REFLECT DEXTROMETHORPHAN ORAL CLEARANCE
      Silvana Borges, Lang Li, Mitchell A. Hamman, David R. Jones, Stephen D. Hall and J. Christopher Gorski
      Drug Metabolism and Disposition July 2005, 33 (7) 1052-1055; DOI: https://doi.org/10.1124/dmd.104.003459

  7. Li, Weihua

    1. POSSIBLE PATHWAY(S) OF TESTOSTERONE EGRESS FROM THE ACTIVE SITE OF CYTOCHROME P450 2B1: A STEERED MOLECULAR DYNAMICS SIMULATION
      Weihua Li, Hong Liu, Emily E. Scott, Frauke Gräter, James R. Halpert, Xiaoming Luo, Jianhua Shen and Hualiang Jiang
      Drug Metabolism and Disposition July 2005, 33 (7) 910-919; DOI: https://doi.org/10.1124/dmd.105.004200

  8. Li, Xin

    1. LITHOCHOLIC ACID DECREASES EXPRESSION OF UGT2B7 IN CACO-2 CELLS: A POTENTIAL ROLE FOR A NEGATIVE FARNESOID X RECEPTOR RESPONSE ELEMENT
      Yuan Lu, Jean-Marie Heydel, Xin Li, Stacie Bratton, Tim Lindblom and Anna Radominska-Pandya
      Drug Metabolism and Disposition July 2005, 33 (7) 937-946; DOI: https://doi.org/10.1124/dmd.104.003061

  9. Lin, Charles

    1. INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913

  10. Lindblom, Tim

    1. LITHOCHOLIC ACID DECREASES EXPRESSION OF UGT2B7 IN CACO-2 CELLS: A POTENTIAL ROLE FOR A NEGATIVE FARNESOID X RECEPTOR RESPONSE ELEMENT
      Yuan Lu, Jean-Marie Heydel, Xin Li, Stacie Bratton, Tim Lindblom and Anna Radominska-Pandya
      Drug Metabolism and Disposition July 2005, 33 (7) 937-946; DOI: https://doi.org/10.1124/dmd.104.003061

  11. Linnemann, Knud

    1. VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION
      Henriette E. Meyer zu Schwabedissen, Gabriele Jedlitschky, Matthias Gratz, Sierk Haenisch, Knud Linnemann, Christoph Fusch, Ingolf Cascorbi and Heyo K. Kroemer
      Drug Metabolism and Disposition July 2005, 33 (7) 896-904; DOI: https://doi.org/10.1124/dmd.104.003335

  12. Liu, Hong

    1. POSSIBLE PATHWAY(S) OF TESTOSTERONE EGRESS FROM THE ACTIVE SITE OF CYTOCHROME P450 2B1: A STEERED MOLECULAR DYNAMICS SIMULATION
      Weihua Li, Hong Liu, Emily E. Scott, Frauke Gräter, James R. Halpert, Xiaoming Luo, Jianhua Shen and Hualiang Jiang
      Drug Metabolism and Disposition July 2005, 33 (7) 910-919; DOI: https://doi.org/10.1124/dmd.105.004200

  13. Locuson, Charles W.

    1. THREE-DIMENSIONAL QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP ANALYSIS OF CYTOCHROMES P450: EFFECT OF INCORPORATING HIGHER-AFFINITY LIGANDS AND POTENTIAL NEW APPLICATIONS
      Charles W. Locuson and Jan L. Wahlstrom
      Drug Metabolism and Disposition July 2005, 33 (7) 873-878; DOI: https://doi.org/10.1124/dmd.105.004325

  14. Lu, Yuan

    1. LITHOCHOLIC ACID DECREASES EXPRESSION OF UGT2B7 IN CACO-2 CELLS: A POTENTIAL ROLE FOR A NEGATIVE FARNESOID X RECEPTOR RESPONSE ELEMENT
      Yuan Lu, Jean-Marie Heydel, Xin Li, Stacie Bratton, Tim Lindblom and Anna Radominska-Pandya
      Drug Metabolism and Disposition July 2005, 33 (7) 937-946; DOI: https://doi.org/10.1124/dmd.104.003061

  15. Luo, Xiaoming

    1. POSSIBLE PATHWAY(S) OF TESTOSTERONE EGRESS FROM THE ACTIVE SITE OF CYTOCHROME P450 2B1: A STEERED MOLECULAR DYNAMICS SIMULATION
      Weihua Li, Hong Liu, Emily E. Scott, Frauke Gräter, James R. Halpert, Xiaoming Luo, Jianhua Shen and Hualiang Jiang
      Drug Metabolism and Disposition July 2005, 33 (7) 910-919; DOI: https://doi.org/10.1124/dmd.105.004200

  16. Luquita, Marcelo G.

    1. PREVENTION OF MRP2 ACTIVITY IMPAIRMENT IN ETHINYLESTRADIOL-INDUCED CHOLESTASIS BY URSODEOXYCHOLATE IN THE RAT
      Fernando A. Crocenzi, Vanesa D'Andrea, Viviana A. Catania, Marcelo G. Luquita, José M. Pellegrino, J. Elena Ochoa, Aldo D. Mottino and Enrique J. Sánchez Pozzi
      Drug Metabolism and Disposition July 2005, 33 (7) 888-891; DOI: https://doi.org/10.1124/dmd.104.003533

  17. Luu, Minh

    1. INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913

  18. Luukkanen, Leena

    1. KINETIC CHARACTERIZATION OF THE 1A SUBFAMILY OF RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Leena Luukkanen, Jyrki Taskinen, Mika Kurkela, Risto Kostiainen, Jouni Hirvonen and Moshe Finel
      Drug Metabolism and Disposition July 2005, 33 (7) 1017-1026; DOI: https://doi.org/10.1124/dmd.105.004093

M

  1. Maher, Jonathan

    1. TISSUE DISTRIBUTION AND ONTOGENY OF MOUSE ORGANIC ANION TRANSPORTING POLYPEPTIDES (OATPS)
      Xingguo Cheng, Jonathan Maher, Chuan Chen and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 1062-1073; DOI: https://doi.org/10.1124/dmd.105.003640

  2. Maher, Jonathan M.

    1. TISSUE DISTRIBUTION AND HEPATIC AND RENAL ONTOGENY OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) FAMILY IN MICE
      Jonathan M. Maher, Angela L. Slitt, Nathan J. Cherrington, Xingguo Cheng and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 947-955; DOI: https://doi.org/10.1124/dmd.105.003780
    2. INDUCTION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN FAMILY OF TRANSPORTERS BY CHEMICAL ACTIVATORS OF RECEPTOR-MEDIATED PATHWAYS IN MOUSE LIVER
      Jonathan M. Maher, Xingguo Cheng, Angela L. Slitt, Matthew Z. Dieter and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 956-962; DOI: https://doi.org/10.1124/dmd.105.003798

  3. Mannens, Geert

    1. EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES
      Dirk Roymans, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens and Willem Meuldermans
      Drug Metabolism and Disposition July 2005, 33 (7) 1004-1016; DOI: https://doi.org/10.1124/dmd.104.003046

  4. McCune, Jeannine S.

    1. CONTRIBUTION OF CYP3A5 TO HEPATIC AND RENAL IFOSFAMIDE N-DECHLOROETHYLATION
      Jeannine S. McCune, Linda J. Risler, Brian R. Phillips, Kenneth E. Thummel, David Blough and Danny D. Shen
      Drug Metabolism and Disposition July 2005, 33 (7) 1074-1081; DOI: https://doi.org/10.1124/dmd.104.002279

  5. Meng, Zhiyun

    1. METABOLIC PROFILE OF 1,5-DICAFFEOYLQUINIC ACID IN RATS, AN IN VIVO AND IN VITRO STUDY
      Bo Yang, Zhiyun Meng, Junxing Dong, Liangping Yan, Libo Zou, Zhongming Tang and Guifang Dou
      Drug Metabolism and Disposition July 2005, 33 (7) 930-936; DOI: https://doi.org/10.1124/dmd.104.002154

  6. Merkle, Karlheinz

    1. SYNTHESIS AND CHARACTERIZATION OF SOME NEW PHASE II METABOLITES OF THE ALKYLATOR BENDAMUSTINE AND THEIR IDENTIFICATION IN HUMAN BILE, URINE, AND PLASMA FROM PATIENTS WITH CHOLANGIOCARCINOMA
      Jens Teichert, Reinhard Sohr, Frank Baumann, Lothar Hennig, Karlheinz Merkle, Karel Caca and Rainer Preiss
      Drug Metabolism and Disposition July 2005, 33 (7) 984-992; DOI: https://doi.org/10.1124/dmd.105.003624

  7. Meuldermans, Willem

    1. EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES
      Dirk Roymans, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens and Willem Meuldermans
      Drug Metabolism and Disposition July 2005, 33 (7) 1004-1016; DOI: https://doi.org/10.1124/dmd.104.003046

  8. Meyer zu Schwabedissen, Henriette E.

    1. VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION
      Henriette E. Meyer zu Schwabedissen, Gabriele Jedlitschky, Matthias Gratz, Sierk Haenisch, Knud Linnemann, Christoph Fusch, Ingolf Cascorbi and Heyo K. Kroemer
      Drug Metabolism and Disposition July 2005, 33 (7) 896-904; DOI: https://doi.org/10.1124/dmd.104.003335

  9. Miao, Zhuang

    1. CHARACTERIZATION OF A NOVEL METABOLITE INTERMEDIATE OF ZIPRASIDONE IN HEPATIC CYTOSOLIC FRACTIONS OF RAT, DOG, AND HUMAN BY ESI-MS/MS, HYDROGEN/DEUTERIUM EXCHANGE, AND CHEMICAL DERIVATIZATION
      Zhuang Miao, Amin Kamel and Chandra Prakash
      Drug Metabolism and Disposition July 2005, 33 (7) 879-883; DOI: https://doi.org/10.1124/dmd.105.004036

  10. Michael, Aimee

    1. INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913

  11. Michel, Kimberly

    1. INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913

  12. Mohutsky, Michael A.

    1. THE USE OF A SUBSTRATE CASSETTE STRATEGY TO IMPROVE THE CAPACITY AND THROUGHPUT OF CYTOCHROME P450 INDUCTION STUDIES IN HUMAN HEPATOCYTES
      Michael A. Mohutsky, David M. Petullo and Steven A. Wrighton
      Drug Metabolism and Disposition July 2005, 33 (7) 920-923; DOI: https://doi.org/10.1124/dmd.105.004291

  13. Mottino, Aldo D.

    1. PREVENTION OF MRP2 ACTIVITY IMPAIRMENT IN ETHINYLESTRADIOL-INDUCED CHOLESTASIS BY URSODEOXYCHOLATE IN THE RAT
      Fernando A. Crocenzi, Vanesa D'Andrea, Viviana A. Catania, Marcelo G. Luquita, José M. Pellegrino, J. Elena Ochoa, Aldo D. Mottino and Enrique J. Sánchez Pozzi
      Drug Metabolism and Disposition July 2005, 33 (7) 888-891; DOI: https://doi.org/10.1124/dmd.104.003533

  14. Mullen, William

    1. DISPOSITION AND METABOLISM OF [2-14C]QUERCETIN-4′-GLUCOSIDE IN RATS
      Brigitte A. Graf, William Mullen, Stuart T. Caldwell, Richard C. Hartley, Garry G. Duthie, Michael E. J. Lean, Alan Crozier and Christine A. Edwards
      Drug Metabolism and Disposition July 2005, 33 (7) 1036-1043; DOI: https://doi.org/10.1124/dmd.104.002691

N

  1. Nakajo, Ikumi

    1. IDENTIFICATION OF HMG-CoA REDUCTASE INHIBITORS AS ACTIVATORS FOR HUMAN, MOUSE AND RAT CONSTITUTIVE ANDROSTANE RECEPTOR
      Kaoru Kobayashi, Yosuke Yamanaka, Norihiko Iwazaki, Ikumi Nakajo, Masakiyo Hosokawa, Masahiko Negishi and Kan Chiba
      Drug Metabolism and Disposition July 2005, 33 (7) 924-929; DOI: https://doi.org/10.1124/dmd.104.002741

  2. Negishi, Masahiko

    1. IDENTIFICATION OF HMG-CoA REDUCTASE INHIBITORS AS ACTIVATORS FOR HUMAN, MOUSE AND RAT CONSTITUTIVE ANDROSTANE RECEPTOR
      Kaoru Kobayashi, Yosuke Yamanaka, Norihiko Iwazaki, Ikumi Nakajo, Masakiyo Hosokawa, Masahiko Negishi and Kan Chiba
      Drug Metabolism and Disposition July 2005, 33 (7) 924-929; DOI: https://doi.org/10.1124/dmd.104.002741

  3. Nichols, Ralph C.

    1. ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES
      Trisha L. Noreault, Vsevolod E. Kostrubsky, Sheryl G. Wood, Ralph C. Nichols, Stephen C. Strom, Heidi W. Trask, Steven A. Wrighton, Ronald M. Evans, Judith M. Jacobs, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2005, 33 (7) 993-1003; DOI: https://doi.org/10.1124/dmd.105.003954

  4. Noreault, Trisha L.

    1. ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES
      Trisha L. Noreault, Vsevolod E. Kostrubsky, Sheryl G. Wood, Ralph C. Nichols, Stephen C. Strom, Heidi W. Trask, Steven A. Wrighton, Ronald M. Evans, Judith M. Jacobs, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2005, 33 (7) 993-1003; DOI: https://doi.org/10.1124/dmd.105.003954

  5. Noukens, Jan

    1. EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES
      Dirk Roymans, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens and Willem Meuldermans
      Drug Metabolism and Disposition July 2005, 33 (7) 1004-1016; DOI: https://doi.org/10.1124/dmd.104.003046

O

  1. Ochoa, J. Elena

    1. PREVENTION OF MRP2 ACTIVITY IMPAIRMENT IN ETHINYLESTRADIOL-INDUCED CHOLESTASIS BY URSODEOXYCHOLATE IN THE RAT
      Fernando A. Crocenzi, Vanesa D'Andrea, Viviana A. Catania, Marcelo G. Luquita, José M. Pellegrino, J. Elena Ochoa, Aldo D. Mottino and Enrique J. Sánchez Pozzi
      Drug Metabolism and Disposition July 2005, 33 (7) 888-891; DOI: https://doi.org/10.1124/dmd.104.003533

P

  1. Parikh, Mona

    1. INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913

  2. Pellegrino, José M.

    1. PREVENTION OF MRP2 ACTIVITY IMPAIRMENT IN ETHINYLESTRADIOL-INDUCED CHOLESTASIS BY URSODEOXYCHOLATE IN THE RAT
      Fernando A. Crocenzi, Vanesa D'Andrea, Viviana A. Catania, Marcelo G. Luquita, José M. Pellegrino, J. Elena Ochoa, Aldo D. Mottino and Enrique J. Sánchez Pozzi
      Drug Metabolism and Disposition July 2005, 33 (7) 888-891; DOI: https://doi.org/10.1124/dmd.104.003533

  3. Pentel, P. R.

    1. MONOCLONAL NICOTINE-SPECIFIC ANTIBODIES REDUCE NICOTINE DISTRIBUTION TO BRAIN IN RATS: DOSE- AND AFFINITY-RESPONSE RELATIONSHIPS
      D. E. Keyler, S. A. Roiko, E. Benlhabib, M. G. LeSage, J. V. St. Peter, S. Stewart, S. Fuller, C. T. Le and P. R. Pentel
      Drug Metabolism and Disposition July 2005, 33 (7) 1056-1061; DOI: https://doi.org/10.1124/dmd.105.004234

  4. Petullo, David M.

    1. THE USE OF A SUBSTRATE CASSETTE STRATEGY TO IMPROVE THE CAPACITY AND THROUGHPUT OF CYTOCHROME P450 INDUCTION STUDIES IN HUMAN HEPATOCYTES
      Michael A. Mohutsky, David M. Petullo and Steven A. Wrighton
      Drug Metabolism and Disposition July 2005, 33 (7) 920-923; DOI: https://doi.org/10.1124/dmd.105.004291

  5. Phillips, Brian R.

    1. CONTRIBUTION OF CYP3A5 TO HEPATIC AND RENAL IFOSFAMIDE N-DECHLOROETHYLATION
      Jeannine S. McCune, Linda J. Risler, Brian R. Phillips, Kenneth E. Thummel, David Blough and Danny D. Shen
      Drug Metabolism and Disposition July 2005, 33 (7) 1074-1081; DOI: https://doi.org/10.1124/dmd.104.002279

  6. Poirier, Charles

    1. CYP3A5 GENETIC POLYMORPHISMS IN DIFFERENT ETHNIC POPULATIONS
      Jean-Nicholas Roy, Julie Lajoie, Lynn S. Zijenah, Azemi Barama, Charles Poirier, Brian J. Ward and Michel Roger
      Drug Metabolism and Disposition July 2005, 33 (7) 884-887; DOI: https://doi.org/10.1124/dmd.105.003822

  7. Potter, John D.

    1. GLUCURONIDATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: IDENTIFYING THE ENZYMES RESPONSIBLE IN HUMAN LIVER MICROSOMES
      Gwendolyn E. Kuehl, Johanna W. Lampe, John D. Potter and Jeannette Bigler
      Drug Metabolism and Disposition July 2005, 33 (7) 1027-1035; DOI: https://doi.org/10.1124/dmd.104.002527

  8. Prakash, Chandra

    1. CHARACTERIZATION OF A NOVEL METABOLITE INTERMEDIATE OF ZIPRASIDONE IN HEPATIC CYTOSOLIC FRACTIONS OF RAT, DOG, AND HUMAN BY ESI-MS/MS, HYDROGEN/DEUTERIUM EXCHANGE, AND CHEMICAL DERIVATIZATION
      Zhuang Miao, Amin Kamel and Chandra Prakash
      Drug Metabolism and Disposition July 2005, 33 (7) 879-883; DOI: https://doi.org/10.1124/dmd.105.004036

  9. Preiss, Rainer

    1. SYNTHESIS AND CHARACTERIZATION OF SOME NEW PHASE II METABOLITES OF THE ALKYLATOR BENDAMUSTINE AND THEIR IDENTIFICATION IN HUMAN BILE, URINE, AND PLASMA FROM PATIENTS WITH CHOLANGIOCARCINOMA
      Jens Teichert, Reinhard Sohr, Frank Baumann, Lothar Hennig, Karlheinz Merkle, Karel Caca and Rainer Preiss
      Drug Metabolism and Disposition July 2005, 33 (7) 984-992; DOI: https://doi.org/10.1124/dmd.105.003624

R

  1. Raab, Conrad

    1. INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913

  2. Radominska-Pandya, Anna

    1. LITHOCHOLIC ACID DECREASES EXPRESSION OF UGT2B7 IN CACO-2 CELLS: A POTENTIAL ROLE FOR A NEGATIVE FARNESOID X RECEPTOR RESPONSE ELEMENT
      Yuan Lu, Jean-Marie Heydel, Xin Li, Stacie Bratton, Tim Lindblom and Anna Radominska-Pandya
      Drug Metabolism and Disposition July 2005, 33 (7) 937-946; DOI: https://doi.org/10.1124/dmd.104.003061

  3. Richards, Karen

    1. INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913

  4. Risler, Linda J.

    1. CONTRIBUTION OF CYP3A5 TO HEPATIC AND RENAL IFOSFAMIDE N-DECHLOROETHYLATION
      Jeannine S. McCune, Linda J. Risler, Brian R. Phillips, Kenneth E. Thummel, David Blough and Danny D. Shen
      Drug Metabolism and Disposition July 2005, 33 (7) 1074-1081; DOI: https://doi.org/10.1124/dmd.104.002279

  5. Ritter, Joseph K.

    1. DIFFERENTIAL RATES OF GLUCURONIDATION FOR 7-ETHYL-10-HYDROXY-CAMPTOTHECIN (SN-38) LACTONE AND CARBOXYLATE IN HUMAN AND RAT MICROSOMES AND RECOMBINANT UDP-GLUCURONOSYLTRANSFERASE ISOFORMS
      Melanie N. Tallman, Joseph K. Ritter and Philip C. Smith
      Drug Metabolism and Disposition July 2005, 33 (7) 977-983; DOI: https://doi.org/10.1124/dmd.104.003491

  6. Rodrigues, A. David

    1. INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913

  7. Roger, Michel

    1. CYP3A5 GENETIC POLYMORPHISMS IN DIFFERENT ETHNIC POPULATIONS
      Jean-Nicholas Roy, Julie Lajoie, Lynn S. Zijenah, Azemi Barama, Charles Poirier, Brian J. Ward and Michel Roger
      Drug Metabolism and Disposition July 2005, 33 (7) 884-887; DOI: https://doi.org/10.1124/dmd.105.003822

  8. Roiko, S. A.

    1. MONOCLONAL NICOTINE-SPECIFIC ANTIBODIES REDUCE NICOTINE DISTRIBUTION TO BRAIN IN RATS: DOSE- AND AFFINITY-RESPONSE RELATIONSHIPS
      D. E. Keyler, S. A. Roiko, E. Benlhabib, M. G. LeSage, J. V. St. Peter, S. Stewart, S. Fuller, C. T. Le and P. R. Pentel
      Drug Metabolism and Disposition July 2005, 33 (7) 1056-1061; DOI: https://doi.org/10.1124/dmd.105.004234

  9. Roy, Jean-Nicholas

    1. CYP3A5 GENETIC POLYMORPHISMS IN DIFFERENT ETHNIC POPULATIONS
      Jean-Nicholas Roy, Julie Lajoie, Lynn S. Zijenah, Azemi Barama, Charles Poirier, Brian J. Ward and Michel Roger
      Drug Metabolism and Disposition July 2005, 33 (7) 884-887; DOI: https://doi.org/10.1124/dmd.105.003822

  10. Roymans, Dirk

    1. EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES
      Dirk Roymans, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens and Willem Meuldermans
      Drug Metabolism and Disposition July 2005, 33 (7) 1004-1016; DOI: https://doi.org/10.1124/dmd.104.003046

  11. Rushmore, Thomas H.

    1. INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913

S

  1. Sánchez Pozzi, Enrique J.

    1. PREVENTION OF MRP2 ACTIVITY IMPAIRMENT IN ETHINYLESTRADIOL-INDUCED CHOLESTASIS BY URSODEOXYCHOLATE IN THE RAT
      Fernando A. Crocenzi, Vanesa D'Andrea, Viviana A. Catania, Marcelo G. Luquita, José M. Pellegrino, J. Elena Ochoa, Aldo D. Mottino and Enrique J. Sánchez Pozzi
      Drug Metabolism and Disposition July 2005, 33 (7) 888-891; DOI: https://doi.org/10.1124/dmd.104.003533

  2. Schellens, Jan H. M.

    1. MIDAZOLAM AND CYCLOSPORIN A METABOLISM IN TRANSGENIC MICE WITH LIVER-SPECIFIC EXPRESSION OF HUMAN CYP3A4
      Antonius E. van Herwaarden, Johan W. Smit, Rolf W. Sparidans, Els Wagenaar, Cornelia M. M. van der Kruijssen, Jan H. M. Schellens, Jos H. Beijnen and Alfred H. Schinkel
      Drug Metabolism and Disposition July 2005, 33 (7) 892-895; DOI: https://doi.org/10.1124/dmd.105.004721

  3. Schinkel, Alfred H.

    1. MIDAZOLAM AND CYCLOSPORIN A METABOLISM IN TRANSGENIC MICE WITH LIVER-SPECIFIC EXPRESSION OF HUMAN CYP3A4
      Antonius E. van Herwaarden, Johan W. Smit, Rolf W. Sparidans, Els Wagenaar, Cornelia M. M. van der Kruijssen, Jan H. M. Schellens, Jos H. Beijnen and Alfred H. Schinkel
      Drug Metabolism and Disposition July 2005, 33 (7) 892-895; DOI: https://doi.org/10.1124/dmd.105.004721

  4. Scott, Emily E.

    1. POSSIBLE PATHWAY(S) OF TESTOSTERONE EGRESS FROM THE ACTIVE SITE OF CYTOCHROME P450 2B1: A STEERED MOLECULAR DYNAMICS SIMULATION
      Weihua Li, Hong Liu, Emily E. Scott, Frauke Gräter, James R. Halpert, Xiaoming Luo, Jianhua Shen and Hualiang Jiang
      Drug Metabolism and Disposition July 2005, 33 (7) 910-919; DOI: https://doi.org/10.1124/dmd.105.004200

  5. Sensenhauser, Carlo

    1. EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES
      Dirk Roymans, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens and Willem Meuldermans
      Drug Metabolism and Disposition July 2005, 33 (7) 1004-1016; DOI: https://doi.org/10.1124/dmd.104.003046

  6. Shen, Danny D.

    1. CONTRIBUTION OF CYP3A5 TO HEPATIC AND RENAL IFOSFAMIDE N-DECHLOROETHYLATION
      Jeannine S. McCune, Linda J. Risler, Brian R. Phillips, Kenneth E. Thummel, David Blough and Danny D. Shen
      Drug Metabolism and Disposition July 2005, 33 (7) 1074-1081; DOI: https://doi.org/10.1124/dmd.104.002279

  7. Shen, Jianhua

    1. POSSIBLE PATHWAY(S) OF TESTOSTERONE EGRESS FROM THE ACTIVE SITE OF CYTOCHROME P450 2B1: A STEERED MOLECULAR DYNAMICS SIMULATION
      Weihua Li, Hong Liu, Emily E. Scott, Frauke Gräter, James R. Halpert, Xiaoming Luo, Jianhua Shen and Hualiang Jiang
      Drug Metabolism and Disposition July 2005, 33 (7) 910-919; DOI: https://doi.org/10.1124/dmd.105.004200

  8. Silva, José

    1. EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES
      Dirk Roymans, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens and Willem Meuldermans
      Drug Metabolism and Disposition July 2005, 33 (7) 1004-1016; DOI: https://doi.org/10.1124/dmd.104.003046

  9. Sinclair, Jacqueline F.

    1. ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES
      Trisha L. Noreault, Vsevolod E. Kostrubsky, Sheryl G. Wood, Ralph C. Nichols, Stephen C. Strom, Heidi W. Trask, Steven A. Wrighton, Ronald M. Evans, Judith M. Jacobs, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2005, 33 (7) 993-1003; DOI: https://doi.org/10.1124/dmd.105.003954

  10. Sinclair, Peter R.

    1. ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES
      Trisha L. Noreault, Vsevolod E. Kostrubsky, Sheryl G. Wood, Ralph C. Nichols, Stephen C. Strom, Heidi W. Trask, Steven A. Wrighton, Ronald M. Evans, Judith M. Jacobs, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2005, 33 (7) 993-1003; DOI: https://doi.org/10.1124/dmd.105.003954

  11. Singh, Rominder

    1. INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913

  12. Slitt, Angela L.

    1. TISSUE DISTRIBUTION AND HEPATIC AND RENAL ONTOGENY OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) FAMILY IN MICE
      Jonathan M. Maher, Angela L. Slitt, Nathan J. Cherrington, Xingguo Cheng and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 947-955; DOI: https://doi.org/10.1124/dmd.105.003780
    2. INDUCTION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN FAMILY OF TRANSPORTERS BY CHEMICAL ACTIVATORS OF RECEPTOR-MEDIATED PATHWAYS IN MOUSE LIVER
      Jonathan M. Maher, Xingguo Cheng, Angela L. Slitt, Matthew Z. Dieter and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 956-962; DOI: https://doi.org/10.1124/dmd.105.003798

  13. Smit, Johan W.

    1. MIDAZOLAM AND CYCLOSPORIN A METABOLISM IN TRANSGENIC MICE WITH LIVER-SPECIFIC EXPRESSION OF HUMAN CYP3A4
      Antonius E. van Herwaarden, Johan W. Smit, Rolf W. Sparidans, Els Wagenaar, Cornelia M. M. van der Kruijssen, Jan H. M. Schellens, Jos H. Beijnen and Alfred H. Schinkel
      Drug Metabolism and Disposition July 2005, 33 (7) 892-895; DOI: https://doi.org/10.1124/dmd.105.004721

  14. Smith, Philip C.

    1. DIFFERENTIAL RATES OF GLUCURONIDATION FOR 7-ETHYL-10-HYDROXY-CAMPTOTHECIN (SN-38) LACTONE AND CARBOXYLATE IN HUMAN AND RAT MICROSOMES AND RECOMBINANT UDP-GLUCURONOSYLTRANSFERASE ISOFORMS
      Melanie N. Tallman, Joseph K. Ritter and Philip C. Smith
      Drug Metabolism and Disposition July 2005, 33 (7) 977-983; DOI: https://doi.org/10.1124/dmd.104.003491

  15. Sohr, Reinhard

    1. SYNTHESIS AND CHARACTERIZATION OF SOME NEW PHASE II METABOLITES OF THE ALKYLATOR BENDAMUSTINE AND THEIR IDENTIFICATION IN HUMAN BILE, URINE, AND PLASMA FROM PATIENTS WITH CHOLANGIOCARCINOMA
      Jens Teichert, Reinhard Sohr, Frank Baumann, Lothar Hennig, Karlheinz Merkle, Karel Caca and Rainer Preiss
      Drug Metabolism and Disposition July 2005, 33 (7) 984-992; DOI: https://doi.org/10.1124/dmd.105.003624

  16. Sparidans, Rolf W.

    1. MIDAZOLAM AND CYCLOSPORIN A METABOLISM IN TRANSGENIC MICE WITH LIVER-SPECIFIC EXPRESSION OF HUMAN CYP3A4
      Antonius E. van Herwaarden, Johan W. Smit, Rolf W. Sparidans, Els Wagenaar, Cornelia M. M. van der Kruijssen, Jan H. M. Schellens, Jos H. Beijnen and Alfred H. Schinkel
      Drug Metabolism and Disposition July 2005, 33 (7) 892-895; DOI: https://doi.org/10.1124/dmd.105.004721

  17. St. Peter, J. V.

    1. MONOCLONAL NICOTINE-SPECIFIC ANTIBODIES REDUCE NICOTINE DISTRIBUTION TO BRAIN IN RATS: DOSE- AND AFFINITY-RESPONSE RELATIONSHIPS
      D. E. Keyler, S. A. Roiko, E. Benlhabib, M. G. LeSage, J. V. St. Peter, S. Stewart, S. Fuller, C. T. Le and P. R. Pentel
      Drug Metabolism and Disposition July 2005, 33 (7) 1056-1061; DOI: https://doi.org/10.1124/dmd.105.004234

  18. Stewart, S.

    1. MONOCLONAL NICOTINE-SPECIFIC ANTIBODIES REDUCE NICOTINE DISTRIBUTION TO BRAIN IN RATS: DOSE- AND AFFINITY-RESPONSE RELATIONSHIPS
      D. E. Keyler, S. A. Roiko, E. Benlhabib, M. G. LeSage, J. V. St. Peter, S. Stewart, S. Fuller, C. T. Le and P. R. Pentel
      Drug Metabolism and Disposition July 2005, 33 (7) 1056-1061; DOI: https://doi.org/10.1124/dmd.105.004234

  19. Strom, Stephen C.

    1. ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES
      Trisha L. Noreault, Vsevolod E. Kostrubsky, Sheryl G. Wood, Ralph C. Nichols, Stephen C. Strom, Heidi W. Trask, Steven A. Wrighton, Ronald M. Evans, Judith M. Jacobs, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2005, 33 (7) 993-1003; DOI: https://doi.org/10.1124/dmd.105.003954

  20. Subramanian, Raju

    1. INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913

  21. Sugiyama, Yuichi

    1. REGULATION OF THE CELL SURFACE EXPRESSION OF HUMAN BCRP/ABCG2 BY THE PHOSPHORYLATION STATE OF AKT IN POLARIZED CELLS
      Tappei Takada, Hiroshi Suzuki, Yukiko Gotoh and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2005, 33 (7) 905-909; DOI: https://doi.org/10.1124/dmd.104.003228
    2. P-GLYCOPROTEIN PLAYS A MAJOR ROLE IN THE EFFLUX OF FEXOFENADINE IN THE SMALL INTESTINE AND BLOOD-BRAIN BARRIER, BUT ONLY A LIMITED ROLE IN ITS BILIARY EXCRETION
      Harunobu Tahara, Hiroyuki Kusuhara, Eiichi Fuse and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2005, 33 (7) 963-968; DOI: https://doi.org/10.1124/dmd.105.004192

  22. Suzuki, Hiroshi

    1. REGULATION OF THE CELL SURFACE EXPRESSION OF HUMAN BCRP/ABCG2 BY THE PHOSPHORYLATION STATE OF AKT IN POLARIZED CELLS
      Tappei Takada, Hiroshi Suzuki, Yukiko Gotoh and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2005, 33 (7) 905-909; DOI: https://doi.org/10.1124/dmd.104.003228

T

  1. Tahara, Harunobu

    1. P-GLYCOPROTEIN PLAYS A MAJOR ROLE IN THE EFFLUX OF FEXOFENADINE IN THE SMALL INTESTINE AND BLOOD-BRAIN BARRIER, BUT ONLY A LIMITED ROLE IN ITS BILIARY EXCRETION
      Harunobu Tahara, Hiroyuki Kusuhara, Eiichi Fuse and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2005, 33 (7) 963-968; DOI: https://doi.org/10.1124/dmd.105.004192

  2. Takada, Tappei

    1. REGULATION OF THE CELL SURFACE EXPRESSION OF HUMAN BCRP/ABCG2 BY THE PHOSPHORYLATION STATE OF AKT IN POLARIZED CELLS
      Tappei Takada, Hiroshi Suzuki, Yukiko Gotoh and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2005, 33 (7) 905-909; DOI: https://doi.org/10.1124/dmd.104.003228

  3. Tallman, Melanie N.

    1. DIFFERENTIAL RATES OF GLUCURONIDATION FOR 7-ETHYL-10-HYDROXY-CAMPTOTHECIN (SN-38) LACTONE AND CARBOXYLATE IN HUMAN AND RAT MICROSOMES AND RECOMBINANT UDP-GLUCURONOSYLTRANSFERASE ISOFORMS
      Melanie N. Tallman, Joseph K. Ritter and Philip C. Smith
      Drug Metabolism and Disposition July 2005, 33 (7) 977-983; DOI: https://doi.org/10.1124/dmd.104.003491

  4. Tang, Zhongming

    1. METABOLIC PROFILE OF 1,5-DICAFFEOYLQUINIC ACID IN RATS, AN IN VIVO AND IN VITRO STUDY
      Bo Yang, Zhiyun Meng, Junxing Dong, Liangping Yan, Libo Zou, Zhongming Tang and Guifang Dou
      Drug Metabolism and Disposition July 2005, 33 (7) 930-936; DOI: https://doi.org/10.1124/dmd.104.002154

  5. Taskinen, Jyrki

    1. KINETIC CHARACTERIZATION OF THE 1A SUBFAMILY OF RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Leena Luukkanen, Jyrki Taskinen, Mika Kurkela, Risto Kostiainen, Jouni Hirvonen and Moshe Finel
      Drug Metabolism and Disposition July 2005, 33 (7) 1017-1026; DOI: https://doi.org/10.1124/dmd.105.004093

  6. Teichert, Jens

    1. SYNTHESIS AND CHARACTERIZATION OF SOME NEW PHASE II METABOLITES OF THE ALKYLATOR BENDAMUSTINE AND THEIR IDENTIFICATION IN HUMAN BILE, URINE, AND PLASMA FROM PATIENTS WITH CHOLANGIOCARCINOMA
      Jens Teichert, Reinhard Sohr, Frank Baumann, Lothar Hennig, Karlheinz Merkle, Karel Caca and Rainer Preiss
      Drug Metabolism and Disposition July 2005, 33 (7) 984-992; DOI: https://doi.org/10.1124/dmd.105.003624

  7. Thummel, Kenneth E.

    1. CONTRIBUTION OF CYP3A5 TO HEPATIC AND RENAL IFOSFAMIDE N-DECHLOROETHYLATION
      Jeannine S. McCune, Linda J. Risler, Brian R. Phillips, Kenneth E. Thummel, David Blough and Danny D. Shen
      Drug Metabolism and Disposition July 2005, 33 (7) 1074-1081; DOI: https://doi.org/10.1124/dmd.104.002279

  8. Trask, Heidi W.

    1. ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES
      Trisha L. Noreault, Vsevolod E. Kostrubsky, Sheryl G. Wood, Ralph C. Nichols, Stephen C. Strom, Heidi W. Trask, Steven A. Wrighton, Ronald M. Evans, Judith M. Jacobs, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2005, 33 (7) 993-1003; DOI: https://doi.org/10.1124/dmd.105.003954

U

  1. Unadkat, Jashvant D.

    1. IDENTIFICATION OF CYTOCHROME P450 AND ARYLAMINE N-ACETYLTRANSFERASE ISOFORMS INVOLVED IN SULFADIAZINE METABOLISM
      Helen R. Winter and Jashvant D. Unadkat
      Drug Metabolism and Disposition July 2005, 33 (7) 969-976; DOI: https://doi.org/10.1124/dmd.104.002998

V

  1. van der Kruijssen, Cornelia M. M.

    1. MIDAZOLAM AND CYCLOSPORIN A METABOLISM IN TRANSGENIC MICE WITH LIVER-SPECIFIC EXPRESSION OF HUMAN CYP3A4
      Antonius E. van Herwaarden, Johan W. Smit, Rolf W. Sparidans, Els Wagenaar, Cornelia M. M. van der Kruijssen, Jan H. M. Schellens, Jos H. Beijnen and Alfred H. Schinkel
      Drug Metabolism and Disposition July 2005, 33 (7) 892-895; DOI: https://doi.org/10.1124/dmd.105.004721

  2. van Herwaarden, Antonius E.

    1. MIDAZOLAM AND CYCLOSPORIN A METABOLISM IN TRANSGENIC MICE WITH LIVER-SPECIFIC EXPRESSION OF HUMAN CYP3A4
      Antonius E. van Herwaarden, Johan W. Smit, Rolf W. Sparidans, Els Wagenaar, Cornelia M. M. van der Kruijssen, Jan H. M. Schellens, Jos H. Beijnen and Alfred H. Schinkel
      Drug Metabolism and Disposition July 2005, 33 (7) 892-895; DOI: https://doi.org/10.1124/dmd.105.004721

  3. Van Houdt, Jos

    1. EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES
      Dirk Roymans, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens and Willem Meuldermans
      Drug Metabolism and Disposition July 2005, 33 (7) 1004-1016; DOI: https://doi.org/10.1124/dmd.104.003046

  4. Van Looveren, Cis

    1. EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES
      Dirk Roymans, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens and Willem Meuldermans
      Drug Metabolism and Disposition July 2005, 33 (7) 1004-1016; DOI: https://doi.org/10.1124/dmd.104.003046

W

  1. Wagenaar, Els

    1. MIDAZOLAM AND CYCLOSPORIN A METABOLISM IN TRANSGENIC MICE WITH LIVER-SPECIFIC EXPRESSION OF HUMAN CYP3A4
      Antonius E. van Herwaarden, Johan W. Smit, Rolf W. Sparidans, Els Wagenaar, Cornelia M. M. van der Kruijssen, Jan H. M. Schellens, Jos H. Beijnen and Alfred H. Schinkel
      Drug Metabolism and Disposition July 2005, 33 (7) 892-895; DOI: https://doi.org/10.1124/dmd.105.004721

  2. Wahlstrom, Jan L.

    1. THREE-DIMENSIONAL QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP ANALYSIS OF CYTOCHROMES P450: EFFECT OF INCORPORATING HIGHER-AFFINITY LIGANDS AND POTENTIAL NEW APPLICATIONS
      Charles W. Locuson and Jan L. Wahlstrom
      Drug Metabolism and Disposition July 2005, 33 (7) 873-878; DOI: https://doi.org/10.1124/dmd.105.004325

  3. Ward, Brian J.

    1. CYP3A5 GENETIC POLYMORPHISMS IN DIFFERENT ETHNIC POPULATIONS
      Jean-Nicholas Roy, Julie Lajoie, Lynn S. Zijenah, Azemi Barama, Charles Poirier, Brian J. Ward and Michel Roger
      Drug Metabolism and Disposition July 2005, 33 (7) 884-887; DOI: https://doi.org/10.1124/dmd.105.003822

  4. Weygers, Adri

    1. EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES
      Dirk Roymans, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens and Willem Meuldermans
      Drug Metabolism and Disposition July 2005, 33 (7) 1004-1016; DOI: https://doi.org/10.1124/dmd.104.003046

  5. Winter, Helen R.

    1. IDENTIFICATION OF CYTOCHROME P450 AND ARYLAMINE N-ACETYLTRANSFERASE ISOFORMS INVOLVED IN SULFADIAZINE METABOLISM
      Helen R. Winter and Jashvant D. Unadkat
      Drug Metabolism and Disposition July 2005, 33 (7) 969-976; DOI: https://doi.org/10.1124/dmd.104.002998

  6. Wood, Sheryl G.

    1. ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES
      Trisha L. Noreault, Vsevolod E. Kostrubsky, Sheryl G. Wood, Ralph C. Nichols, Stephen C. Strom, Heidi W. Trask, Steven A. Wrighton, Ronald M. Evans, Judith M. Jacobs, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2005, 33 (7) 993-1003; DOI: https://doi.org/10.1124/dmd.105.003954

  7. Wrighton, Steven A.

    1. THE USE OF A SUBSTRATE CASSETTE STRATEGY TO IMPROVE THE CAPACITY AND THROUGHPUT OF CYTOCHROME P450 INDUCTION STUDIES IN HUMAN HEPATOCYTES
      Michael A. Mohutsky, David M. Petullo and Steven A. Wrighton
      Drug Metabolism and Disposition July 2005, 33 (7) 920-923; DOI: https://doi.org/10.1124/dmd.105.004291
    2. ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES
      Trisha L. Noreault, Vsevolod E. Kostrubsky, Sheryl G. Wood, Ralph C. Nichols, Stephen C. Strom, Heidi W. Trask, Steven A. Wrighton, Ronald M. Evans, Judith M. Jacobs, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2005, 33 (7) 993-1003; DOI: https://doi.org/10.1124/dmd.105.003954

Y

  1. Yamanaka, Yosuke

    1. IDENTIFICATION OF HMG-CoA REDUCTASE INHIBITORS AS ACTIVATORS FOR HUMAN, MOUSE AND RAT CONSTITUTIVE ANDROSTANE RECEPTOR
      Kaoru Kobayashi, Yosuke Yamanaka, Norihiko Iwazaki, Ikumi Nakajo, Masakiyo Hosokawa, Masahiko Negishi and Kan Chiba
      Drug Metabolism and Disposition July 2005, 33 (7) 924-929; DOI: https://doi.org/10.1124/dmd.104.002741

  2. Yan, Liangping

    1. METABOLIC PROFILE OF 1,5-DICAFFEOYLQUINIC ACID IN RATS, AN IN VIVO AND IN VITRO STUDY
      Bo Yang, Zhiyun Meng, Junxing Dong, Liangping Yan, Libo Zou, Zhongming Tang and Guifang Dou
      Drug Metabolism and Disposition July 2005, 33 (7) 930-936; DOI: https://doi.org/10.1124/dmd.104.002154

  3. Yang, Bo

    1. METABOLIC PROFILE OF 1,5-DICAFFEOYLQUINIC ACID IN RATS, AN IN VIVO AND IN VITRO STUDY
      Bo Yang, Zhiyun Meng, Junxing Dong, Liangping Yan, Libo Zou, Zhongming Tang and Guifang Dou
      Drug Metabolism and Disposition July 2005, 33 (7) 930-936; DOI: https://doi.org/10.1124/dmd.104.002154

Z

  1. Zijenah, Lynn S.

    1. CYP3A5 GENETIC POLYMORPHISMS IN DIFFERENT ETHNIC POPULATIONS
      Jean-Nicholas Roy, Julie Lajoie, Lynn S. Zijenah, Azemi Barama, Charles Poirier, Brian J. Ward and Michel Roger
      Drug Metabolism and Disposition July 2005, 33 (7) 884-887; DOI: https://doi.org/10.1124/dmd.105.003822

  2. Zou, Libo

    1. METABOLIC PROFILE OF 1,5-DICAFFEOYLQUINIC ACID IN RATS, AN IN VIVO AND IN VITRO STUDY
      Bo Yang, Zhiyun Meng, Junxing Dong, Liangping Yan, Libo Zou, Zhongming Tang and Guifang Dou
      Drug Metabolism and Disposition July 2005, 33 (7) 930-936; DOI: https://doi.org/10.1124/dmd.104.002154
Back to top

In this issue